LifeStance Health Group, Inc. LFST
$12.52
-$0.10-0.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.58B | 1.49B | 1.42B | 1.37B | 1.32B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.58B | 1.49B | 1.42B | 1.37B | 1.32B |
| Cost of Revenue | 1.05B | 1.01B | 963.19M | 923.33M | 888.39M |
| Gross Profit | 531.85M | 487.24M | 461.10M | 444.24M | 428.09M |
| SG&A Expenses | 397.91M | 388.05M | 382.24M | 380.55M | 369.77M |
| Depreciation & Amortization | 54.56M | 54.32M | 54.75M | 55.99M | 57.55M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.51B | 1.45B | 1.40B | 1.36B | 1.32B |
| Operating Income | 79.39M | 44.87M | 24.11M | 7.70M | 769.00K |
| Income Before Tax | 66.99M | 33.59M | 12.36M | -11.72M | -21.67M |
| Income Tax Expenses | 16.39M | 10.40M | 2.70M | -2.60M | -5.52M |
| Earnings from Continuing Operations | 50.60 | 23.20 | 9.66 | -9.12 | -16.15 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.60M | 23.20M | 9.66M | -9.12M | -16.15M |
| EBIT | 79.39M | 44.87M | 24.11M | 7.70M | 769.00K |
| EBITDA | 133.94M | 99.19M | 78.86M | 63.69M | 58.32M |
| EPS Basic | 0.13 | 0.06 | 0.02 | -0.02 | -0.04 |
| Normalized Basic EPS | 0.11 | 0.06 | 0.02 | -0.02 | -0.03 |
| EPS Diluted | 0.13 | 0.06 | 0.02 | -0.03 | -0.05 |
| Normalized Diluted EPS | 0.11 | 0.05 | 0.02 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 1.54B | 1.55B | 1.54B | 1.54B | 1.53B |
| Average Diluted Shares Outstanding | 1.57B | 1.57B | 1.56B | 1.55B | 1.54B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |